NCT01729832

Brief Summary

Many hospitals, including the Ohio State University Medical Center, will take pictures of the blood vessels in a patient's abdomen before they decide to perform a breast reconstruction using the patient's own tissue. These pictures are called computed tomography (CT) angiograms and are like a map of each patient's anatomy. However, no study has been reported that determined how accurate these pictures are at showing the surgeon where all of the blood vessels were located. This study will try to determine if these pictures are missing any blood vessels that are found during surgery and if the pictures show the correct location of the vessels

Trial Health

15
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Jan 2011

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 10, 2011

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2012

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

November 14, 2012

Completed
6 days until next milestone

First Posted

Study publicly available on registry

November 20, 2012

Completed
Last Updated

April 13, 2017

Status Verified

April 1, 2017

Enrollment Period

1.5 years

First QC Date

November 14, 2012

Last Update Submit

April 12, 2017

Conditions

Outcome Measures

Primary Outcomes (2)

  • The number of perforators that are found intraoperatively but not seen preoperatively on CT angiogram images

    Up to 2 years

  • Whether the preoperative CT angiography allowed the surgeon to accurately predict the perforator vessels that were actually used in the final flap design and transfer

    Up to 2 years

Secondary Outcomes (1)

  • Position of the vessels on the imaging correlate to actual location on the abdominal wall for those perforator vessels that are identified both on preoperative review of the images and located during flap dissection

    Up to 2 years

Study Arms (1)

Supportive care (image-guided breast reconstruction)

EXPERIMENTAL

Patients undergo DIEP flap breast reconstruction using the StealthStation navigation system.

Procedure: breast reconstructionProcedure: intraoperative imaging

Interventions

Undergo DIEP flap breast reconstruction using the StealthStation navigation system

Also known as: Mammaplasty
Supportive care (image-guided breast reconstruction)

Undergo DIEP flap breast reconstruction using the StealthStation navigation system

Supportive care (image-guided breast reconstruction)

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with histologically confirmed breast carcinoma or breast carcinoma in situ desiring unilateral or bilateral deep inferior epigastric perforator (DIEP) flap breast reconstruction
  • Patients must be candidates for elective surgery, without clinically significant cardiac or pulmonary disease (New York Heart Association \[NYHA\] class III/IV), without infection requiring antibiotics, and without serious illness requiring the use of steroids
  • Patients must have normal kidney function and no allergy to intravenous (IV) dye

You may not qualify if:

  • Patients with previous abdominal donor site flaps will be excluded along with patients with previous extensive surgery to the anterior abdomen
  • Patients with a weight of over 300 pounds or a body size not supported by the CT scanner will be excluded
  • Patients who are expected to undergo postoperative radiation therapy will be excluded

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Links

MeSH Terms

Conditions

Carcinoma, Intraductal, NoninfiltratingBreast Carcinoma In SituBreast Neoplasms

Interventions

Mammaplasty

Condition Hierarchy (Ancestors)

AdenocarcinomaCarcinomaNeoplasms, Glandular and EpithelialNeoplasms by Histologic TypeNeoplasmsCarcinoma in SituNeoplasms, Ductal, Lobular, and MedullaryNeoplasms by SiteBreast DiseasesSkin DiseasesSkin and Connective Tissue Diseases

Intervention Hierarchy (Ancestors)

Cosmetic TechniquesTherapeuticsPlastic Surgery ProceduresSurgical Procedures, Operative

Study Officials

  • Ergun Kocak, MD

    Ohio State University

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 14, 2012

First Posted

November 20, 2012

Study Start

January 10, 2011

Primary Completion

July 1, 2012

Study Completion

July 1, 2012

Last Updated

April 13, 2017

Record last verified: 2017-04